BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9369226)

  • 1. Insulin dependent tyrosine phosphorylation of the tyrosine internalisation motif of TGN38 creates a specific SH2 domain binding site.
    Stephens DJ; Banting G
    FEBS Lett; 1997 Oct; 416(1):27-9. PubMed ID: 9369226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of interaction between adaptor-complex medium chains and the tyrosine-based sorting motifs of TGN38 and lgp120.
    Stephens DJ; Banting G
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):567-72. PubMed ID: 9794796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen.
    Xu R; Abramson J; Fridkin M; Pecht I
    J Immunol; 2001 Dec; 167(11):6394-402. PubMed ID: 11714805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the medium chain subunit of the AP-2 adaptor complex does not influence its interaction with the tyrosine based internalisation motif of TGN38.
    Crump CM; Banting G
    FEBS Lett; 1999 Feb; 444(2-3):195-200. PubMed ID: 10050758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase.
    Milarski KL; Lazar DF; Wiese RJ; Saltiel AR
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):579-83. PubMed ID: 7539611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases.
    Philosof-Oppenheimer R; Hampe CS; Schlessinger K; Fridkin M; Pecht I
    Eur J Biochem; 2000 Feb; 267(3):703-11. PubMed ID: 10651806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA; Lienhard GE; Lavan BE
    Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient trafficking of TGN38 from the endosome to the trans-Golgi network requires a free hydroxyl group at position 331 in the cytosolic domain.
    Roquemore EP; Banting G
    Mol Biol Cell; 1998 Aug; 9(8):2125-44. PubMed ID: 9693371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase.
    Ahmed Z; Smith BJ; Kotani K; Wilden P; Pillay TS
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):665-8. PubMed ID: 10417330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K.
    Sánchez-Margalet V; Najib S
    FEBS Lett; 1999 Jul; 455(3):307-10. PubMed ID: 10437794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain.
    Bos K; Wraight C; Stanley KK
    EMBO J; 1993 May; 12(5):2219-28. PubMed ID: 8491209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein.
    Su Z; Xu P; Ni F
    Eur J Biochem; 2004 May; 271(9):1725-36. PubMed ID: 15096211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
    Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
    Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
    Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tyrosine-containing internalization motif in the cytoplasmic domain of TGN38/41 lies within a nascent helix.
    Wilde A; Dempsey C; Banting G
    J Biol Chem; 1994 Mar; 269(10):7131-6. PubMed ID: 8125922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
    Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
    J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.